Phase 4
Completed N=19
Plaque Psoriasis Study in Pediatric Subjects
Source: ClinicalTrials.gov NCT02186665 ↗Enrolled (actual)
19
Serious AEs
0.0%
Results posted
Mar 2017
Primary outcomePrimary: Success of Investigator's Global Assessment (IGA) — 3; 7 Participants
◆ Published Evidence
No publication linked
No peer-reviewed publication reporting this trial's results has been linked yet. This can indicate results are unpublished — a known publication-bias signal. We re-check periodically.
Summary
The purpose of this study is to compare the safety, efficacy and calcium metabolism of up to 8 weeks of treatment with calcitriol 3 mcg/g ointment versus its vehicle, when used twice daily, without occlusion, to treat children aged 2 to 12 years, with plaque psoriasis.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Success of Investigator's Global Assessment (IGA) |
3; 7 | — |
Eligibility Criteria
Inclusion Criteria
- Male or female 2 to 12 years of age
- Clinical diagnosis of stable mild to moderate plaque psoriasis
Exclusion Criteria
- Other forms of psoriasis
- Hypercalcemia
- Past history of kidney stones
- Vitamin D deficiency
- Other concomitant dermatological disease
Data sourced from ClinicalTrials.gov (NCT02186665). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.